X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse J.B.Chemicals with ACTAVIS INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs ACTAVIS (US) - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 J.B.CHEMICALS   ACTAVIS
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
ACTAVIS
Dec-14
J.B.CHEMICALS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs31817,672-   
Low Rs20010,779-   
Sales per share (Unadj.) Rs148.03,182.2-  
Earnings per share (Unadj.) Rs19.1-397.1-  
Cash flow per share (Unadj.) Rs23.9292.0-  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.96,902.2-  
Shares outstanding (eoy) m84.82265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.74.5 39.1%   
Avg P/E ratio x13.6-35.8 -37.9%  
P/CF ratio (eoy) x10.848.7 22.2%  
Price / Book Value ratio x2.02.1 97.4%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,9513,782,610 0.6%   
No. of employees `0002.721.6 12.7%   
Total wages/salary Rs m1,8410-   
Avg. sales/employee Rs Th4,590.939,173.9 11.7%   
Avg. wages/employee Rs Th673.40-   
Avg. net profit/employee Rs Th592.1-4,888.5 -12.1%   
INCOME DATA
Net Sales Rs m12,551846,156 1.5%  
Other income Rs m542-2,112 -25.6%   
Total revenues Rs m13,093844,045 1.6%   
Gross profit Rs m2,055108,701 1.9%  
Depreciation Rs m412183,224 0.2%   
Interest Rs m9626,689 0.4%   
Profit before tax Rs m2,088-103,324 -2.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-7,579 0.0%   
Tax Rs m469-5,312 -8.8%   
Profit after tax Rs m1,619-105,591 -1.5%  
Gross profit margin %16.412.8 127.4%  
Effective tax rate %22.55.1 436.9%   
Net profit margin %12.9-12.5 -103.3%  
BALANCE SHEET DATA
Current assets Rs m7,778445,816 1.7%   
Current liabilities Rs m4,358325,131 1.3%   
Net working cap to sales %27.214.3 191.0%  
Current ratio x1.81.4 130.2%  
Inventory Days Days5558 94.2%  
Debtors Days Days8066 120.7%  
Net fixed assets Rs m5,713103,324 5.5%   
Share capital Rs m1700-   
"Free" reserves Rs m10,5470-   
Net worth Rs m10,9371,835,282 0.6%   
Long term debt Rs m0961,724 0.0%   
Total assets Rs m15,5743,363,468 0.5%  
Interest coverage x22.8-2.9 -794.8%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.80.3 320.4%   
Return on assets %11.0-2.3 -469.3%  
Return on equity %14.8-5.8 -257.2%  
Return on capital %20.0-3.0 -663.1%  
Exports to sales %48.70-   
Imports to sales %7.10-   
Net fx Rs m4,8840-   
CASH FLOW
From Operations Rs m1,397145,302 1.0%  
From Investments Rs m-320-347,907 0.1%  
From Financial Activity Rs m-1,196195,474 -0.6%  
Net Cashflow Rs m-102-7,132 1.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 64.78 Rs / USD

Compare J.B.CHEMICALS With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare J.B.CHEMICALS With: UNICHEM LAB  PLETHICO PHARMA  LUPIN LTD  SUN PHARMA  AJANTA PHARMA  



Today's Market

Sensex Opens Firm; IT Stocks Gain(09:30 am)

Asian stocks were relatively subdued in the early trade today, with most regional indices hovering around the flat line following the softer lead stateside.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 21, 2018 11:33 AM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS